Ultromics
Healthcare Software · United Kingdom · 51-200 Employees
View Company Info for Free
Overview
Headquarters
Business Park South 4630 Kingsgate Casca...Phone Number
+44 8081968558Website
www.ultromics.comRevenue
$21 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
3
3
2
3
2
1
About Ultromics
Founded out of the University of Oxford, Ultromics is redefining cardiovascular care with FDA-cleared, AI-powered tools that enhance echocardiographic diagnosis. Built in partnership with the NHS and Mayo Clinic, its EchoGo® platform helps clinicians detect complex heart diseases earlier and more accurately using nothing more than a standard ultrasound scan. Ultromics is backed by leading investors and U.S. healthcare systems and is on a mission to transform how heart disease is diagnosed and treated.Explore more
Ultromics Org Chart
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Ultromics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if Ultromics had a recent Job posting/layoffs
Check if Ultromics has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once Ultromics has new funding data
Earning: See what the market has to say on Ultromics recently announced quarterly report
Website visits: Recent activity has been detected on your website
Ultromics, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when Ultromics launches new products
Congratulate Masked Content for being promoted to Masked Content at Ultromics
Check out if Ultromics is spiking on competitors!
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Compare Similar Companies to Ultromics
Compare insights from companies similar to Ultromics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Ultromics is experiencing very low activity levels compared to other companies in the Software sector.
What does this means?
Ultromics is drawing exceptional interest within the Software industry, suggesting notable developments or strong market momentum, learn more about Ultromics.
Ultromics financials insights
Gather financial insights about Ultromics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2017
Angel/Seed
$2.8M
2018
Series A
$10M
2021
Series B
$33M
2025
Series C
$55M
Ultromics Tech Stack
A closer look at the technologies used by Ultromics
Most Recent Scoops
Person-Based
Funding
Funding
Person-Based
Open Position
Person-Based
Ultromics News & Media
Ultromics Study Shows AI Could Improve Early Detection of Cardiac Amyloidosis
Earlier and more precise detection of cardiac amyloidosis is critical: once considered rare and overlooked, it is now moving into the mainstream of cardiology and public awareness, with new drugs, national campaigns and data demonstrating survival benefits that are enhanced when patients...Ultromics Lands $55M Series C to Tackle Undiagnosed Heart Failure at Scale
AI Heart Failure Diagnostics Innovator Makes it Possible to Catch Deadly Heart Failure Earlier by Analyzing the Most Common Heart Scan in the World and Proactively Alerting Clinicians FDA-Cleared, Reimbursed by Medicare, and Live in Top U.S. Hospitals, Ultromics is Now Scaling Nationwide to Make Early Heart Failure Detection Part of Routine Cardiac Care, WhereverUltromics secures £41m Series C funding to expand AI solution - Digital Health
Ultromics, a provider of AI-driven cardiology solutions, has raised $55m (£41m) in Series C financing to scale its technology across the US.Ultromics Lands $55M Series C to Tackle Undiagnosed Heart Failure at Scale
AI heart failure diagnostics innovator makes it possible to catch deadly heart failure earlier by analyzing the most common heart scan in the world and proactively alerting clinicians FDA-cleared, reimbursed by Medicare, and live in top U.S. hospitals, Ultromics is now scaling nationwide...
Read more news
Top Healthcare Software Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Ultromics
Sign Up For FreeTo access detailed company insights
Founded out of the University of Oxford, Ultromics is redefining cardiovascular care with FDA-cleared, AI-powered tools that enhance echocardiographic diagnosis. Built in partnership with the NHS and Mayo Clinic, its EchoGo® platform helps clinicians detect complex heart diseases earlier and more accurately using nothing more than a standard ultras... Read More
